Cargando…
Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer
SIMPLE SUMMARY: Most patients with advanced non-small cell lung cancer (NSCLC) do not respond to programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) axis blockade, highlighting the need for the identification of new targets for immune checkpoint inhibition. In this study, we use...
Autores principales: | Vathiotis, Ioannis A., MacNeil, Tyler, Zugazagoitia, Jon, Syrigos, Konstantinos N., Aung, Thazin Nwe, Gruver, Aaron M., Vaillancourt, Peter, Hughes, Ina, Hinton, Steve, Driscoll, Kyla, Rimm, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957629/ https://www.ncbi.nlm.nih.gov/pubmed/33804482 http://dx.doi.org/10.3390/cancers13051024 |
Ejemplares similares
-
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer
por: MacNeil, Tyler, et al.
Publicado: (2021) -
Spatial characterization and quantification of CD40 expression across cancer types
por: Bates, Katherine M., et al.
Publicado: (2023) -
CD200/CD200 receptor axis in psoriasis vulgaris
por: Ismail, Aisha A., et al.
Publicado: (2020) -
CD200:CD200R Interactions and Their Importance in Immunoregulation
por: Kotwica-Mojzych, Katarzyna, et al.
Publicado: (2021) -
Rabbit CD200R binds host CD200 but not CD200-like proteins from poxviruses
por: Akkaya, Munir, et al.
Publicado: (2016)